Nisoldipine Pregnancy and Breastfeeding Warnings
Nisoldipine is also known as: Sular
Nisoldipine Pregnancy Warnings
Nisoldipine has been assigned to pregnancy category C by the FDA. Animal data have revealed evidence of fetotoxicity (but not teratogenicity) after rats and rabbits were given doses that resulted in maternal toxicity (reduced maternal weight gain). In pregnant rats, increased fetal resorption was observed at 100 mg/kg/day, and decreased fetal weight was observed at both 30 and 100 mg/kg/day (which are approximately 5 and 16 times the maximum recommended human dose (MRHD) on a mg/m2 basis). In pregnant rabbits, decreased fetal and placental weights were observed at a dose of 30 mg/kg/day, approximately 10 times the MRHD when compared on a mg/m2 basis. In a study in which pregnant monkeys (both treated and control) had high rates of abortion and mortality, the only surviving fetus from a group exposed to a maternal dose of 100 mg/kg/day (approximately 30 times the MRHD on a mg/m2 basis) presented with forelimb and vertebral abnormalities not previously seen in control monkeys of the same strain. There are no controlled data in human pregnancy. Nisoldipine should only be given during pregnancy when benefit outweighs risk.
Nisoldipine Breastfeeding Warnings
There are no data on the excretion of nisoldipine into human milk. The manufacturer states that a decision should be made to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.